Uncategorized

Hospital occupancy rates were higher in 2024 than 2019. If occupancy rates trend up, the nation could face a bed shortage by 2032, according to researchers.

A cautionary tale illustrates how forging a deal with a Big Pharma can have unexpected and far-reaching tax consequences.

2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.

The agreement, in which Merck will pay the biotech an undisclosed initial sum to license drugs targeting a solid tumor, could net Epitopea up to $300 million down the line.

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective alternative to Merck’s Welireg in renal cell carcinoma.

Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, alleging i2025 njury linked to its HPV shot Gardasil.

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma and head-and-neck cancer, with several readouts slated for the second half of 2025.

Executive coaches can help executives take their game to the next level in four key ways, from improving their self-awareness to reshaping their thinking.

WhatsApp es una de las aplicaciones de mensajería más utilizadas en el mundo. Muchas personas buscan formas de rastrear un número de WhatsApp sin ser descubiertos, ya sea por seguridad, preocupación por un ser querido o control parental. Aunque no existe un método …

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.